| Intervention(n = 62) | Control(n = 53) | Ta | p-value | Effect Size (Cohen’s d) |
---|---|---|---|---|---|
Pre-test (range 1–60) | 18.31 (SD = 5.43) | 16.58 (SD = 4.30) | 1.86 | 0.65 | 0.35 |
Data interpretation (1–5) | 1.55 (SD = 0.88) | 1.34 (SD = 0.62) | 1.49 | 0.140 |  |
Signs and symptoms (1–5) | 1.79 (SD = 0.55) | 1.62 (SD = 0.49) | 1.72 | 0.088 |  |
Diagnosis (1–5) | 1.55 ((SD = 0.56) | 1.38 (SD = 0.56) | 1.62 | 0.107 |  |
Treatment (1–5) | 1.47 (SD = 0.62) | 1.25 (SD = 0.48) | 2.17 | 0.032 |  |
Post-test (range 1–60) | 38.0 (SD = 7.36) | 28.55 (SD = 5.89) | 7.52 | < 0.001 | 1.41 |
Data interpretation (1–5) | 3.71 (SD = 1.27) | 2.87 (SD = 1.00) | 3.89 | < 0.001 |  |
Signs and symptoms (1–5) | 3.05 (SD = 0.66) | 2.34 (SD = 0.48) | 6.47 | < 0.001 |  |
Diagnosis (1–5) | 3.10 (SD = 0.56) | 2.34 (SD = 0.65) | 6.62 | < 0.001 |  |
Treatment (1–5) | 3.10 (SD = 0.62) | 2.15 (SD = 0.79) | 7.03 | < 0.001 |  |
2 weeks post-test(range 1–60) | 34.0 (SD = 7.32) | 23.81 (SD = 6.16) | 8.00 | < 0.001 | 1.50 |
Data interpretation (1–5) | 3.82 (SD = 1.25) | 2.53 (SD = 0.99) | 6.08 | < 0.001 |  |
Signs and symptoms (1–5) | 2.66 (SD = 0.75) | 2.08 (SD = 0.47) | 5.10 | < 0.001 |  |
Diagnosis (1–5) | 2.66 (SD = 0.63) | 1.87 (SD = 0.65) | 6.65 | < 0.001 |  |
Treatment (1–5) | 2.44 (SD = 0.78) | 1.53 (SD = 0.58) | 7.15 | < 0.001 |  |